CTeL Appoints New Leadership for AI Blue Ribbon Collaborative to Advance AI Integration in Healthcare

The Center for Telehealth & e-Health Law (CTeL) has announced new leadership for its Artificial Intelligence (AI) Blue Ribbon Collaborative, a key initiative supporting healthcare organizations in navigating the clinical and legal implications of AI. The Collaborative, which brings together experts from diverse disciplines, serves as an independent resource to aid healthcare entities in integrating AI effectively and responsibly into clinical practice, adhering to rigorous ethical and regulatory standards.

The newly appointed leadership team comprises esteemed professionals with backgrounds in population health, data science, neurology, liberal arts, and law. Their combined expertise will bolster CTeL's mission of guiding healthcare organizations as they leverage AI to improve patient care and outcomes, while ensuring compliance with legal and ethical standards.

Leadership Team Members

  • Chair: Dr. Fei Wang, Professor of Population Health Sciences at Weill Cornell Medicine, Cornell University. Dr. Wang is renowned for his pioneering work in AI-driven population health and predictive analytics, with a focus on data-informed healthcare solutions.

  • Vice Chair: Dr. Haipeng Chen, Associate Professor of Data Science at the College of William and Mary. With a focus on algorithmic transparency and fairness, Dr. Chen brings essential insights into the ethical use of AI in healthcare.

  • Member at Large: Dr. Marcelo Matiello, Assistant Professor of Neurology at Harvard Medical School. Dr. Matiello provides clinical expertise, particularly on AI's implications for patient care in neurological fields.

  • Science & Tech Chair: Dr. Xiaotong Shen, John Black Johnston Distinguished Professor at the University of Minnesota. Dr. Shen is an authority on AI applications in clinical and operational settings and will lead initiatives on cutting-edge advancements in AI and machine learning.

  • Law & Policy Chair: Dr. Charles Keckler, Director of the Doctor of Law and Policy Program and Professor of the Practice. With significant experience in health law and policy, Dr. Keckler will guide the Collaborative’s discussions on regulatory frameworks crucial to responsible AI adoption in healthcare.

A Mission to Guide Ethical AI Implementation in Healthcare

The Collaborative's new leadership reflects CTeL’s dedication to equipping healthcare organizations with the guidance they need to address the challenges of AI implementation responsibly. "The appointment of these accomplished leaders strengthens CTeL’s commitment to serving as a trusted resource for healthcare organizations grappling with the unique challenges of AI implementation," said Christa Natoli, Executive Director of CTeL. "Their combined expertise will drive forward our mission to ensure that AI adoption in healthcare is safe, ethical, and aligned with the latest regulatory standards."

"The appointment of these accomplished leaders strengthens CTeL’s commitment to serving as a trusted resource for healthcare organizations grappling with the unique challenges of AI implementation," said Christa Natoli, Executive Director of CTeL.

Focus Areas and Activities of the AI Blue Ribbon Collaborative

The AI Blue Ribbon Collaborative provides a comprehensive range of resources addressing regulatory compliance, coding, reimbursement, and ethical considerations for AI in healthcare. Through its webinars, policy briefings, and working groups, the Collaborative keeps healthcare organizations informed about the latest AI trends and compliance requirements, reinforcing CTeL’s commitment to fostering safe, responsible, and impactful AI use.

For more information on CTeL’s AI initiatives read our RPM session summaries below:

CTeL RPM Summit Highlights—AI’s Game-Changing Role in Remote Patient Monitoring

Unpacking the Future of Data-Driven Healthcare: Clinical Outcomes, Financial Strategies, and AI Integration.

Previous
Previous

Breaking News: OMB Approves DEA's Final Rule Extending COVID-19 Telemedicine Flexibilities for Controlled Medications

Next
Next

Privacy in the Age of Remote Patient Monitoring: Insights and Actions from CTeL’s Annual RPM Conference